Clinical interpretation of enteric molecular diagnostic tests

G. A.M. Tarr; P. I. Tarr; S. B. Freedman

doi:10.1016/j.cmi.2019.08.018

Clinical interpretation of enteric molecular diagnostic tests

G. A.M. Tarr
, P. I. Tarr
, S. B. Freedman

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1454-1456
Number of pages	3
Journal	Clinical Microbiology and Infection
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/j.cmi.2019.08.018
State	Published - Dec 2019
Externally published	Yes

Bibliographical note

Funding Information:
Outside the current work, P.I.T. reports personal fees as a consultant and membership on the scientific advisory board for MediBeacon Inc.; he also holds equity in the company. P.I.T. and S.B.F. report personal fees as consultants for Takeda Pharmaceuticals, and P.I.T. reports consulting fees for the Bill & Melinda Gates Foundation on infant infections. S.B.F. reports non-financial support from Luminex Corporation, BioM?rieux and Copan Diagnostics to support research activities. In addition, PIT has a patent 20190142976 pending to MediBeacon Inc., and is an unpaid consultant to Immunova relating to development of a therapeutic agent for Shiga toxin-producing E. coli. S.B.F. is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness.

Publisher link

10.1016/j.cmi.2019.08.018

Find It

Find It at U of M Libraries

Cite this

@article{e4b4867a112b4a7bb292413ac2ac82ea,

title = "Clinical interpretation of enteric molecular diagnostic tests",

author = "Tarr, \{G. A.M.\} and Tarr, \{P. I.\} and Freedman, \{S. B.\}",

note = "Funding Information: Outside the current work, P.I.T. reports personal fees as a consultant and membership on the scientific advisory board for MediBeacon Inc.; he also holds equity in the company. P.I.T. and S.B.F. report personal fees as consultants for Takeda Pharmaceuticals, and P.I.T. reports consulting fees for the Bill \& Melinda Gates Foundation on infant infections. S.B.F. reports non-financial support from Luminex Corporation, BioM?rieux and Copan Diagnostics to support research activities. In addition, PIT has a patent 20190142976 pending to MediBeacon Inc., and is an unpaid consultant to Immunova relating to development of a therapeutic agent for Shiga toxin-producing E. coli. S.B.F. is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness.",

year = "2019",

month = dec,

doi = "10.1016/j.cmi.2019.08.018",

language = "English (US)",

volume = "25",

pages = "1454--1456",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "12",

}

TY - JOUR

T1 - Clinical interpretation of enteric molecular diagnostic tests

AU - Tarr, G. A.M.

AU - Tarr, P. I.

AU - Freedman, S. B.

N1 - Funding Information: Outside the current work, P.I.T. reports personal fees as a consultant and membership on the scientific advisory board for MediBeacon Inc.; he also holds equity in the company. P.I.T. and S.B.F. report personal fees as consultants for Takeda Pharmaceuticals, and P.I.T. reports consulting fees for the Bill & Melinda Gates Foundation on infant infections. S.B.F. reports non-financial support from Luminex Corporation, BioM?rieux and Copan Diagnostics to support research activities. In addition, PIT has a patent 20190142976 pending to MediBeacon Inc., and is an unpaid consultant to Immunova relating to development of a therapeutic agent for Shiga toxin-producing E. coli. S.B.F. is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness.

PY - 2019/12

Y1 - 2019/12

UR - https://www.scopus.com/pages/publications/85072595435

UR - https://www.scopus.com/pages/publications/85072595435#tab=citedBy

U2 - 10.1016/j.cmi.2019.08.018

DO - 10.1016/j.cmi.2019.08.018

M3 - Comment/debate

C2 - 31491461

AN - SCOPUS:85072595435

SN - 1198-743X

VL - 25

SP - 1454

EP - 1456

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 12

ER -

Clinical interpretation of enteric molecular diagnostic tests

Bibliographical note

Publisher link

Find It

Other files and links

Cite this